Author profile

Ross I. Berbeco, PhD

Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School

AuthorsPoster
Theranostic Aguix Nanoparticles As an MRI Contrast Agent for Tumor Delineation

AGuIX nanoparticles, composed of a polysiloxane core with gadolinium chelates, are a theranostic agent, providing both MRI contrast and radiosensitization. The ongoing NanoBrainMets clinical trial looks to evaluate the therapeutic efficacy of AGuIX by quantif...

Poster Program · Therapy Physics
AuthorsPoster
Truebeam Hypersight Hounsfield Unit Accuracy for Dose Calculation

To evaluate the dosimetric accuracy of plans calculated on the Varian TrueBeam HyperSight cone beam CT (CTHS) imager upgrade compared to current fan beam simulation CT (CTSim) solutions towards online adaptive radiotherapy.

Poster Program · Therapy Physics
AuthorsPaper
Design Optimization for Enhanced Energy Separation In a Kv Dual-Layer Imaging

Dual-layer imagers (DLIs) enable simultaneous acquisition of low- and high-energy images in a single exposure, offering detector-based spectral imaging capability for the on-board kV imaging systems of conventional linear accelerators towards avoiding motion...

Proffered Program · Therapy Physics